What is the treatment for isoniazid-induced psychosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Isoniazid-Induced Psychosis

Immediately discontinue isoniazid and administer pyridoxine (vitamin B6) supplementation, as pyridoxine deficiency is the primary mechanism underlying isoniazid-induced psychosis. 1, 2

Immediate Management

Discontinue Isoniazid

  • Stop isoniazid therapy immediately upon recognition of psychotic symptoms. 3, 4
  • Do not rechallenge with isoniazid, as more than 80% of patients rechallenged experienced recurrence of psychotic symptoms. 5
  • Psychotic symptoms typically resolve partially or completely after isoniazid discontinuation. 3

Pyridoxine Administration

  • Administer pyridoxine (vitamin B6) supplementation as the primary treatment intervention. 1, 2
  • Pyridoxine deficiency is the key pathogenic mechanism, as isoniazid inhibits pyridoxine-dependent enzymes and depletes vitamin B6 stores. 1, 3
  • The specific dosing of pyridoxine for treating established psychosis is not well-defined in the literature, but supplementation should be initiated promptly. 2

Pharmacological Management of Persistent Symptoms

Antipsychotic Therapy

  • If psychotic symptoms persist after isoniazid discontinuation and pyridoxine supplementation, initiate treatment with an atypical antipsychotic. 3
  • Start with risperidone 2 mg/day or olanzapine 7.5-10 mg/day as first-line agents due to better tolerability and lower extrapyramidal side effects. 6
  • In the reported case by Levine and Rosenblatt, olanzapine successfully resolved persistent psychotic symptoms after isoniazid discontinuation. 3
  • Monitor response over 4-6 weeks before considering medication changes. 6

Adjunctive Benzodiazepines

  • Consider short-term benzodiazepines as adjuncts to help stabilize acute agitation or severe anxiety, though use caution with long-term administration. 6

Clinical Presentation and Timeline

Symptom Recognition

  • Delusions and/or hallucinations are the most common presenting symptoms. 5
  • Additional manifestations include psychomotor disturbances, disorganized speech, abnormal behavior, sleep disturbances, hostility, confusion, and cognitive difficulties. 5
  • Visual hallucinations (including bright colors and strange designs) may occur as part of the clinical picture. 7

Temporal Pattern

  • Psychotic symptoms most frequently develop within the first 2 months of isoniazid treatment. 5
  • Onset may be particularly early in patients aged 18 years or younger. 5
  • Symptoms typically manifest within 30 minutes to 3 hours in acute overdose situations. 7

Tuberculosis Treatment Continuation

Alternative Anti-TB Regimen

  • Substitute rifampin-based regimens without isoniazid for continued tuberculosis treatment. 8
  • Four months of daily rifampin is a preferred alternative regimen with high effectiveness and safety. 8
  • Three months of daily rifampin plus ethambutamol can be considered as an alternative continuation phase. 8

Prevention Strategies

Prophylactic Pyridoxine

  • Routine pyridoxine supplementation during isoniazid therapy should be systematic to prevent neuropsychiatric complications. 1
  • This is particularly important in high-risk populations including slow acetylators, diabetics, patients with hepatic insufficiency, elderly patients, and those with alcohol use disorder. 1

Risk Factor Assessment

  • Identify patients with family or personal history of mental illness, as these are predisposing factors for isoniazid-induced psychosis. 1
  • Monitor all patients receiving isoniazid for psychotic and neuropsychiatric symptoms, especially during the first 2 months of therapy. 5

Common Pitfalls to Avoid

  • Do not continue isoniazid after psychotic symptoms emerge, as this will perpetuate the adverse reaction. 3, 4
  • Do not attempt rechallenge with isoniazid, given the high recurrence rate of psychotic symptoms. 5
  • Do not delay pyridoxine supplementation while waiting for psychiatric consultation or antipsychotic initiation. 2
  • Do not assume psychosis is due to underlying psychiatric illness without first considering medication-induced etiology in patients on isoniazid. 1, 3
  • Do not overlook the need for alternative tuberculosis treatment, as discontinuing isoniazid requires substitution with effective anti-TB therapy to prevent treatment failure. 8

References

Research

[Behavioral disorders after treatment with isoniazid].

Bulletin de la Societe de pathologie exotique (1990), 2001

Research

Pyridoxine in isoniazid-induced psychosis.

Sudanese journal of paediatrics, 2022

Research

Isoniazid-induced psychosis.

The Annals of pharmacotherapy, 1998

Guideline

Treatment for Post-Trauma Psychosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.